In a previous microarray study on CLL disease, Rahmatpanah et al., (2009) found that ADAM12 was methylated in CD38highpatients and high-risk CLL patients showed 31-92% of CD38 expression. This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.